SSRIs and TDCS Enhance Post-stroke Motor Recovery
Stroke, Motor
About this trial
This is an interventional treatment trial for Stroke focused on measuring stroke, motor recovery, transcranial direct current stimulation, selective serotonin reuptake inhibitors
Eligibility Criteria
Inclusion Criteria:
- aged 20-80;
- first-onset stroke
- brain image confirmed unilateral subcortical infarction
- moderate to severe upper-limb impairment (SAFE score <8).
- 3 days to 4 weeks after stroke onset
- stable medical condition
Exclusion Criteria:
- metal implants, such as electrodes or pacemaker
- epilepsy history or active spikes from EEG recording
- major depression or taking psychoactive drugs
- alcoholism or drug abuse history
- combined with other severe neurological or psychiatric diagnoses
- pregnancy or breastfeeding;
- other contraindications to brain MRI, such as severe claustrophobia
- intolerance to electrical stimulation
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Sham Comparator
Placebo Comparator
Placebo Comparator
Real tDCS + Citalopram + Rehabilitation
Sham tDCS + Citalopram + Rehabilitation
Real tDCS + Placebo + Rehabilitation
Sham tDCS + Placebo + Rehabilitation
Real tDCS, 2 mA for 20 mins per session, 10 sessions within 2 weeks Citalopram 10mg oral intake daily for 3 months, since 2 weeks before tDCS
Sham tDCS, ramped up over 10 seconds and then reduced to 0mA, 10 sessions within 2 weeks Citalopram 10mg oral intake daily for 3 months, since 2 weeks before tDCS
Real tDCS, 2 mA for 20 mins per session, 10 sessions within 2 weeks Placebo oral intake daily for 3 months, since 2 weeks before tDCS
Sham tDCS, ramped up over 10 seconds and then reduced to 0mA, 10 sessions within 2 weeks Placebo oral intake daily for 3 months, since 2 weeks before tDCS